CP3R and AJH’s Performance for Colon and Rectal Cancers
ADJUVANT CHEMOTHERAPY FOR NODE POSITIVE PATIENTS
Adjuvant Chemotherapy for Node Positive Patients
Adjuvant chemotherapy is considered or administered within four months (120 days) of diagnosis for patients under the age of 80 with AJCC Stage III (lymph node positive) colon cancer. Abington – Jefferson Health’s compliance is favorable at 94.7%, compared to all CoC-approved programs’ norm of 93.2%.
REGIONAL LYMPH NODES IN SURGICALLY RESECTED PATIENTS
Regional Lymph Nodes in Surgically Resected Patients
At least 12 regional lymph nodes are removed and pathologically examined for resected colon cancer. The compliance rate for Abington – Jefferson Health’s compliance at 86.3% needs improvement, compared to all CoC-approved programs’ norm of 87.9%.
RADIATION THERAPY IN RECTAL CARCINOMAS
Radiation Therapy in Rectal Carcinomas
Radiation therapy is considered or administered within six months of diagnosis for patients under age 80 with clinical or pathologic AJCC T4N0M0 or Stage III receiving surgical resection for rectal cancer. Abington – Jefferson Health’s compliance with this standard at 75% reflects the chemotherapy arm randomization in clinical trial participation, compared to all CoC-approved programs’ norm of 85.4%.